Transmolecular Imaging of Recurrent Prostate Carcinoma With Exploration of Genomic Markers Differences Between Local and Distant Recurrence
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 02 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 02 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 16 May 2017 Results comparing Fluciclovine (18F) Pet-Ct and Mri for detection of recurrent prostate cancer, presented at the 112th Annual Meeting of the American Urological Association